Gyre Therapeutics (GYRE) announced the publication of the manuscript titled “Hydronidone for the Treatment of Liver Fibrosis Associated with ...

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.

Learn how the RB209 Nutrient Management Guide impacts nitrogen application in winter wheat trials at Terrington St Clement, Norfolk.

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

Implementing the ventilator-associated events (VAE) prevention protocol at Community Health Network has yielded remarkable results. After two years of ...

This protocol serves as a patient-centred alternative to randomised controlled trials for interventions where clinical equipoise is lacking. Methods and analysis The PKIDS is a collaborative learning ...

3. Participant has completed treatment per protocol in a Novartis study of secukinumab (unless otherwise specified in a parent study protocol). Participants, who derive benefit from the treatment with ...

Our protocol uses a multidisciplinary approach to overcome these ... 54 For each hand, 60 puffs will be presented randomly interspersed with 60 sham trials. To prevent habituation, no more than two ...

Background Following the results of randomized clinical trials supporting the use of mechanical thrombectomy ... and Comprehensive Stroke Centers (CSCs); and update Emergency Medical Services (EMS) ...